Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 72 citing articles:

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
Francesco Angelucci, Kateřina Čechová, Martin Vališ, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 128
Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease
Sha Ke, Zhaohui Yang, Fei Yang, et al.
Yonsei Medical Journal (2019) Vol. 60, Iss. 7, pp. 640-640
Open Access | Times Cited: 109
Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
Serena Silvestro, Placido Bramanti, Emanuela Mazzon
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3979-3979
Open Access | Times Cited: 100
The Regulation of microRNAs in Alzheimer's Disease
Xianjuan Kou, Dandan Chen, Ning Chen
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 96
MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
Wei Wei, Zhiyong Wang, Lina Ma, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 86
The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Elisabetta Lauretti, Konrad Dabrowski, Domenico Praticò
Ageing Research Reviews (2021) Vol. 71, pp. 101425-101425
Open Access | Times Cited: 74
Calcium channelopathies and intellectual disability: a systematic review
Miriam Kessi, Baiyu Chen, Jing Peng, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 58
Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
Edward O. Olufunmilayo, R. M. Damian Holsinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12498-12498
Open Access | Times Cited: 29
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 14
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Knockdown of lncRNA SNHG1 attenuated Aβ25-35-inudced neuronal injury via regulating KREMEN1 by acting as a ceRNA of miR-137 in neuronal cells
Hui Wang, Bo Lü, Jie Chen
Biochemical and Biophysical Research Communications (2019) Vol. 518, Iss. 3, pp. 438-444
Closed Access | Times Cited: 61
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
Yuan Zhang, Yanfang Zhao, Xiang Ao, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 52
miRNA Involvement in Cerebral Ischemia-Reperfusion Injury
Maria Adriana Neag, Andrei-Otto Mitre, Codrin-Constantin Burlacu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 32
Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer's disease.
Majid Khodayi, Mohammad Khalaj‐Kondori, Mohammad Ali Hoseinpour Feizi, et al.
PubMed (2022) Vol. 21, pp. 772-785
Closed Access | Times Cited: 31
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 22
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis
Néha Datta, Charlotte Johnson, Dina Kao, et al.
Pharmacological Research (2023) Vol. 194, pp. 106870-106870
Open Access | Times Cited: 19
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
Alex Cleber Improta‐Caria, Carolina Kymie Vasques Nonaka, Bruno Raphael Ribeiro Cavalcante, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4977-4977
Open Access | Times Cited: 49
Targeting microglia L‐type voltage‐dependent calcium channels for the treatment of central nervous system disorders
Sarah C. Hopp
Journal of Neuroscience Research (2020) Vol. 99, Iss. 1, pp. 141-162
Open Access | Times Cited: 42
SIRT5 Represses Neurotrophic Pathways and Aβ Production in Alzheimer’s Disease by Targeting Autophagy
Shanshan Wu, Yafen Wei, Jingxin Li, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 23, pp. 4428-4437
Open Access | Times Cited: 40
miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells
Nan Zhang, Weiwei Li, Chunmei Lv, et al.
Neuroreport (2019) Vol. 31, Iss. 3, pp. 205-212
Closed Access | Times Cited: 40
A machine learning approach to unmask novel gene signatures and prediction of Alzheimer's disease within different brain regions
Abhibhav Sharma, Pinki Dey
Genomics (2021) Vol. 113, Iss. 4, pp. 1778-1789
Open Access | Times Cited: 32
Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence
Martin L. Pall
Current Alzheimer Research (2022) Vol. 19, Iss. 2, pp. 119-132
Open Access | Times Cited: 20
Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?
Ludovica Filippini, Nadine J. Ortner, Teresa Kaserer, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 10, pp. 1289-1303
Open Access | Times Cited: 11
MicroRNA alterations in neuropathologic cognitive disorders with an emphasis on dementia: Lessons from animal models
Gozal Bahlakeh, Ali Gorji, Hamid Soltani, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 2, pp. 806-823
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top